background human immunodefici virus type hiv infect viral agent gradual extinguish immune system result acquire deficit syndrome aid aim studi construct rnaposit control base armor ar rna technology use model method m matures coat protein gene post pol clone meta plasmid prepare transform escherichia coli strain bl de express induce mm isopropyllthiodgalactopyranosid iptv c h obtain fabric precinct purify polyethylene glycol sephacryl chromatography result static value treatment danse nase confirm transmits electron microscopy gel awards electrophoresis tenfor serial dilute realtime per assay rang detect admit r value slope standard curve concur post could use base launch nous assay agent readily avail laboratory research center noninfecti highly resist ribonucleas enzyme reduce risk infect clinic laboratory 